4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-22-004545
Chief Scientific Officer acquired 4,392 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellon Steven F. Chief Scientific Officer | 2022-05-25 | Option exercise | +675 | $0.73 | $493 | 116,382 | D |
| Bellon Steven F. Chief Scientific Officer | 2022-05-25 | Option exercise | +3,717 | $3.72 | $13,827 | 120,099 | D |
| Derivatives | |||||||
| Bellon Steven F. Chief Scientific Officer | 2022-05-25 | Option exercise · Stock Options (Right to buy) | −675 | 0 | D | ||
| Bellon Steven F. Chief Scientific Officer | 2022-05-25 | Option exercise · Stock Options (Right to buy) | −3,717 | 5,574 | D | ||
Loading xslF345X03/primarydocument.xml…